New research on cannabis and ketamine‐buprenorphine released at APA annual meeting
Alcoholism & Drug Abuse Weekly · 25.05.2026 · 38 (21) · 4-5
DOI: 10.1002/adaw.34924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcoholism & Drug Abuse Weekly, online erschienen am 21.05.2026. Verfasst von Alison Knopf.
Abstract (Originalsprache)
New research on the relationship between cannabis and psychosis was released, and a presentation on how low‐dose buprenorphine combined with ketamine reduced suicidality in adults with major depressive disorder was published and presented at the annual meeting of the American Psychiatric Association (APA).
Zitieren
APA
Knopf, A. (2026). New research on cannabis and ketamine‐buprenorphine released at APA annual meeting. Alcoholism & Drug Abuse Weekly, 38(21), 4-5. https://doi.org/10.1002/adaw.34924
Vancouver
Knopf A. New research on cannabis and ketamine‐buprenorphine released at APA annual meeting. Alcoholism & Drug Abuse Weekly. 2026;38(21):4-5. doi:10.1002/adaw.34924
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {New research on cannabis and ketamine‐buprenorphine released at APA annual meeting},
journal = {Alcoholism & Drug Abuse Weekly},
year = {2026},
volume = {38},
number = {21},
pages = {4--5},
doi = {10.1002/adaw.34924}
}
EUVIMED